What Is MT1?

 

MT1 (Melanotan-1, also known as afamelanotide) is a synthetic peptide analogue of alpha-melanocyte-stimulating hormone (α-MSH). It is studied for its effects on skin pigmentation, photoprotection, and melanin production. MT1 works by stimulating pathways involved in natural pigment formation rather than acting as a hormone related to appetite or metabolism.

 

MT1 is not a weight-loss medication. Its primary research focus involves skin response to ultraviolet (UV) exposure and pigmentation support.

 

How Does MT1 Work?

 

MT1 interacts with melanocortin receptors that regulate pigment production:

 

• Melanocortin-1 receptors (MC1R) — Stimulate melanin production within the skin.

• Melanin signaling — Encourages increased pigment formation, which may contribute to tanning and UV protection.

• Cellular photoprotection pathways — Studied for potential support against UV-related skin stress.

 

Rather than directly darkening the skin like a dye, MT1 works by enhancing the body’s natural melanin response.

 

Potential Benefits?

 

• Support for gradual skin pigmentation

• Photoprotection and UV tolerance

• More even tanning response in some individuals

• Skin health in specific medical conditions

 

Side Effects and Safety Considerations?

 

Reported effects may include:

 

• Nausea or flushing

• Increased freckling or darkening of existing moles

• Fatigue or mild headache

• Injection-site irritation with subcutaneous use

 

Because MT1 influences pigment pathways, skin changes should be monitored carefully. Long-term safety considerations may vary depending on individual response and exposure to sunlight.

 

Recommended Usage Information?

 

Estimated Half-Life is Approximately 30–60 minutes, although biological effects may last longer due to receptor activation.

Why it matters:
• MT1 does not remain in the bloodstream for days like long-acting metabolic peptides
• Often discussed with more frequent administration
• Pigmentation effects build gradually over time rather than immediately

 

Steady state concepts used for long-acting weekly medications do not apply in the same way to MT1. Instead, consistent administration over time may allow melanin levels and visible effects to develop progressively.

​

Start on a daily dose of 0.2mg, and adjust accordingly

 

Gradual increases are typically preferred over rapid escalation to help manage tolerability. Higher amounts are not always necessary — maintaining a consistent approach once desired pigmentation is achieved may help reduce unwanted side effects.

​

Our pens have an adjustable doseage of 0.2-2mg, and have a shelf life of 12-18month.